Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Oct 29, 2024$0.50
P/E Ratio
N/A
Market Cap
$1.88M
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
Overview
Trading Information
Company